COMPUTATIONAL DESIGN OF NORBORNANE-BASED HIV-1 PROTEASE INHIBITORS

被引:4
|
作者
Zhang, Dawei [1 ]
Yu, Liu Ze [1 ]
Huang, Philip Lin [2 ]
Lee-Huang, Sylvia [3 ]
Zhang, John Z. H. [4 ,5 ]
机构
[1] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 637371, Singapore
[2] Amer Biosci, Boston, MA 02114 USA
[3] NYU, Dept Biochem, Langone Med Ctr, New York, NY 10016 USA
[4] E China Normal Univ, Dept Phys, State Key Lab Precis Spect, Shanghai 200062, Peoples R China
[5] NYU, Dept Chem, New York, NY 10003 USA
关键词
HIV-1; protease; norbornane-based inhibitor; linear interaction energy; FREE-ENERGY; LIGAND BINDING;
D O I
10.1142/S0219633610005773
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of norbornane-based HIV-1 protease (PR) inhibitors are designed theoretically to displace the tetrahedrally coordinated internal water molecule that bridges inhibitor to flaps via hydrogen bonds. These designed inhibitors use the norbornenone oxygen atom to mimic this structural water molecule and contain diols to interact with the carboxylate oxygens of catalytic aspartates. The binding free energies were estimated by modified linear interaction energy approach [Zoete H, Michielin O, Karplus M, J Comput Aided Mol Des 17: 861, 2003], in which the binding free energy is written as a linear combination of the electrostatic interaction energy between PR and the ligand, E-elec, the van der Waals interaction energy between PR and the ligand, E-vdW, and the difference of the solvation free energies of the complex, the receptor, and the isolated ligand, Delta G(solv). The equation obtained in previous work [Da W. Zhang, Philip Lin Huang, Sylvia Lee-Huang, John Z. H. Zhang, J Theor Comput Chem 7:485, 2008] is applied directly to calculate the binding free energy of designed norbornane-based HIV-1 PR inhibitors.
引用
收藏
页码:471 / 485
页数:15
相关论文
共 50 条
  • [41] Inhibitors of HIV-1 protease: A major success of structure-assisted drug design
    Wlodawer, A
    Vondrasek, J
    ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1998, 27 : 249 - 284
  • [42] Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance
    Vicente, ACP
    Agwale, SM
    Otsuki, K
    Njouku, OM
    Jelpe, D
    Idoko, JA
    Caride, E
    Brindeiro, RM
    Tanuri, A
    VIRUS GENES, 2001, 22 (02) : 181 - 186
  • [43] Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors
    Zhu, Mei
    Shan, Qi
    Ma, Ling
    Dong, Biao
    Wang, Juxian
    Zhang, Guoning
    Wang, Minghua
    Zhou, Jinming
    Cen, Shan
    Wang, Yucheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [44] Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors
    Babu, S. N. Narendra
    Rangappa, K. S.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) : 874 - 880
  • [45] Study of the Binding Free Energies between HIV-1 Protease and Its Inhibitors
    Yi Changhong
    Zhang Qinggang
    ACTA CHIMICA SINICA, 2010, 68 (20) : 2029 - 2034
  • [46] Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals
    Olajuyigbe, Folasade M.
    Demitri, Nicola
    De Zorzi, Rita
    Geremia, Silvano
    MOLECULES, 2016, 21 (11)
  • [47] Structural exploration of hydroxyethylamines as HIV-1 protease inhibitors: new features identified
    Amin, S. A.
    Adhikari, N.
    Bhargava, S.
    Jha, T.
    Gayen, S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2018, 29 (05) : 385 - 408
  • [48] Coarse-grained Molecular Dynamics of Inhibitors Binding into HIV-1 Protease
    Li, Dechang
    Ji, Baohua
    Liu, Ming S.
    Hwang, K. C.
    Huang, Yonggang
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 4: IMAGE PROCESSING, BIOSIGNAL PROCESSING, MODELLING AND SIMULATION, BIOMECHANICS, 2010, 25 : 623 - 625
  • [49] Synthesis of dibenzyl iminodiacetic derivatives as potential inhibitors of HIV-1 aspartyl protease
    Abalain, C
    Langlois, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (02) : 155 - 160
  • [50] Computational studies of HIV-1 integrase and its inhibitors
    Nunthaboot, Nadtanet
    Pianwanit, Somsak
    Parasuk, Vudhichai
    Kokpol, Sirirat
    Briggs, James M.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (03) : 160 - 190